The Combination of Serum Total IgE and Blood Eosinophil Levels as a Predictor of Response to Phototherapy Treatment in Patients with Atopic Dermatitis
Table 1
Comparison of demographics, clinical characteristics, and duration of phototherapy between AD patients who responded to treatment and those who did not respond.
Nonresponders
Responders
Total
value
Age (years)
Valid N
51
31
82
0.174
Mean (SD)
44.4 (25.2)
36.0 (19.8)
41.2 (23.6)
Median [IQR]
44.0 [20.0–65.0]
30.0 [19.0–53.0]
32.5 [20.0–62.0]
[Min–Max]
[6.0–91.0]
[16.0–83.0]
[6.0–91.0]
Sex
Male
34 (66.7%)
18 (58.1%)
52 (63.4%)
0.433
Female
17 (33.3%)
13 (41.9%)
30 (36.6%)
Improvement in pruritus
Yes
14 (27.5%)
30 (96.8%)
44 (53.7%)
<0.001
No
37 (72.5%)
1 (3.2%)
38 (46.3%)
Hospitalization (days)
Valid N
51
31
82
0.217
Mean (SD)
9.3 (5.5)
7.6 (3.9)
8.7 (5.0)
Median [IQR]
8.0 [5.0–12.0]
7.0 [5.0–9.0]
7.5 [5.0–11.0]
[Min–Max]
[2.0–24.0]
[2.0–18.0]
[2.0–24.0]
Phototherapy course duration (weeks)
Valid N
51
31
82
0.081
Mean (SD)
12.3 (10.1)
8.7 (8.0)
10.9 (9.4)
Median [IQR]
10.0 [5.0–14.0]
7.0 [3.0–12.0]
8.5 [4.0–12.0]
[Min–Max]
[1.0–52.0]
[1.0–40.0]
[1.0–52.0]
Full/partial course
Full
32 (62.7%)
16 (51.6%)
48 (58.5%)
0.321
Partial
19 (37.3%)
15 (48.4%)
34 (41.5%)
Systemic treatment
No
28 (54.9%)
29 (93.5%)
57 (69.5%)
<0.001
Yes
23 (45.1%)
2 (6.5%)
25 (30.5%)
Atopic background
No
21 (41.2%)
9 (29.0%)
30 (36.6%)
0.268
Yes
30 (58.8%)
22 (71.0%)
52 (63.4%)
SD, standard deviation; IQR, interquartile range; Min, minimum; Max, maximum. P value <0.05 is considered significant.
